Publication Name	World Journal of Clinical Cases
Manuscript ID	78708
Country	Taiwan

Received	2022-07-11 03:33
Peer-Review Started	2022-07-11 03:35
To Make the First Decision
Return for Revision	2022-08-20 02:59
Revised	2022-08-20 16:18
Second Decision	2022-09-19 03:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-09-20 10:26
Articles in Press	2022-09-20 10:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-10-18 01:39
Publish the Manuscript Online	2022-10-27 04:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Minireviews
Article Title	Surgical intervention for acute pancreatitis in the COVID-19 era
Manuscript Source	Invited Manuscript
All Author List	Yu-Jang Su and Tse-Hao Chen
ORCID	Author(s) ORCID Number Yu-Jang Su http://orcid.org/0000-0003-0218-1944
Funding Agency and Grant Number
Corresponding Author	Yu-Jang Su, MD, Assistant Professor, Director, Doctor, Teacher, Toxicology Division, Emergency Department, MacKay Memorial Hospital, No. 92 Sec 2, North Chung-Shan Road, Taipei 10449, Taiwan. yjsu.5885@mmh.org.tw
Key Words	2019-nCoV; Complications; COVID-19; Pancreatitis; Surgery
Core Tip	Approximately 5%-10% of cases of acute pancreatitis (AP) develop necrotizing or hemorrhagic pancreatitis and require surgical intervention. Idiopathic causes were the leading etiology (57.1%) of coronavirus disease 2019 (COVID-19)-related AP. In COVID-19-related pancreatitis, gastrointestinal symptoms developed 1.7 days later than respiratory symptoms (9.0 d vs 7.3 d). Regarding examination of the pancreatitis, there was a 57.5% reduction in endoscopic retrograde cholangiopancreatography in 2020 compared to 2019. Moreover, COVID-19-related AP is associated with a 2.7-fold admission rate, 3.4-fold mortality rate, and 3-fold intensive care unit admission rate than non-COVID-19-related AP.
Publish Date	2022-10-27 04:55
Citation	Su YJ, Chen TH. Surgical intervention for acute pancreatitis in the COVID-19 era. World J Clin Cases 2022; 10(31): 11292-11298
URL	https://www.wjgnet.com/2307-8960/full/v10/i31/11292.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i31.11292

Full Article (PDF)	WJCC-10-11292.pdf
Full Article (Word)	WJCC-10-11292.docx
Manuscript File	78708_Auto_Edited-JLW.docx
Answering Reviewers	78708-Answering reviewers.pdf
Audio Core Tip	78708-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78708-Conflict-of-interest statement.pdf
Copyright License Agreement	78708-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	78708-Language certificate.pdf
Peer-review Report	78708-Peer-review(s).pdf
Scientific Misconduct Check	78708-Bing-Chen YL-2.png
Scientific Editor Work List	78708-Scientific editor work list.pdf